Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
A Reproducible Deep-Learning-Based Computer-Aided Diagnosis Tool for Frontotemporal Dementia Using MONAI and Clinica
Andrea Termine1, Carlo Fabrizio1, Carlo Caltagirone2
1Data Science Unit, IRCCS Santa Lucia Foundation, 00143 Rome, Italy.
This study introduces a reproducible workflow for developing Artificial Intelligence (AI) Computer-Aided Diagnosis (CAD) tools for 3D MRI data, specifically for detecting frontotemporal dementia (FTD). The developed AI model demonstrated strong performance and improved understanding of diagnostic markers.
Area of Science:
- Biomedical Imaging
- Artificial Intelligence in Medicine
- Neuroimaging Analysis
Background:
- Clinical implementation of AI-based Computer-Aided Diagnosis (CAD) tools is hindered by unstandardized development practices.
- A lack of reproducible workflows for 3D MRI data hinders AI tool development in clinical settings.
Purpose of the Study:
- To develop an easily reproducible and reliable CAD tool for 3D MRI data using standardized frameworks.
- To train a Deep Learning (DL) algorithm for frontotemporal dementia (FTD) detection and ensure reproducibility.
- To apply Explainable AI (XAI) methods to understand and improve the DL model's behavior.
Main Methods:
- Utilized the Clinica and MONAI frameworks for standardized medical imaging practices.
- Trained a DL algorithm on the NIFD database for FTD detection from 3D MRI data.
- Applied attention maps from XAI to identify key brain regions influencing the DL model's decisions.
Main Results:
- The DL model achieved 0.80 accuracy, 1 sensitivity, 0.6 specificity, 0.83 F1-score, and 0.86 AUC for FTD classification.
- Explainable AI highlighted that the model's decisions were driven by hallmark brain areas associated with FTD.
- The standardized methodology provides a benchmark for FTD classification and aids in understanding model behavior.
Conclusions:
- The proposed standardized methodology facilitates reproducible development of AI-based CAD tools for neuroimaging.
- Standardization and explainability are crucial for regulatory approval and accelerating AI adoption in healthcare.
- This approach can improve the efficacy and safety evaluation of CAD tools, speeding up their integration into clinical practice.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
09:33Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...